Ligand validation:3RAR

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 3RAR designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3RAR_NAG_A_991	71%	62%	0.106	0.925	0.58	0.86	-	1	1	0	100%	0.9333
1LPO_NAG_A_991	84%	16%	0.06	0.921	1.44	2.2	1	7	0	0	100%	0.9333
1LPN_NAG_A_991	82%	20%	0.063	0.918	1.22	2.12	1	4	0	0	100%	0.9333
1LPP_NAG_A_991	82%	24%	0.065	0.918	1.27	1.83	2	5	0	0	100%	0.9333
1LPM_NAG_A_991	78%	38%	0.068	0.91	0.59	1.82	-	5	0	0	100%	0.56
1LPS_NAG_A_991	72%	23%	0.07	0.893	1.23	1.94	1	6	0	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.